Structural investigation of the HIV-1 envelope glycoprotein gp160 cleavage site, 2: Relevance of an N-terminal helix

被引:7
|
作者
Oliva, R
Falcigno, L
D'Auria, G
Dettin, M
Scarinci, C
Pasquato, A
Di Bello, C
Paolillo, L
机构
[1] Univ Naples Federico II, Dipartimento Chim, I-80126 Naples, Italy
[2] Univ Naples Federico II, CNR, Ist Biostrutture & Bioimmagini, I-80134 Naples, Italy
[3] Univ Padua, Dipartimento Proc Chim Ingn, I-35131 Padua, Italy
关键词
conformation analysis; gp160; HIV; molecular modeling; NMR spectroscopy;
D O I
10.1002/cbic.200200541
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Proteolytic activation of the HIV-1 envelope glycoprotein gp160 is selectively performed by the proprotein convertase furin at the C terminus of the sequence R508-E-K-R511 (site 1), in spite of the presence of another consensus sequence, Lys500-Ala-Lys-Arg503 (site 2). On the basis of the solution structural analysis of the synthetic peptide p498, spanning the gp160 sequence Pro498-Gly516, we previously suggested a possible role of an N-terminal helix in regulating the exposure and accessibility of the gp160 physiological cleavage site, enclosed in a loop. Here we report on the activity and conformation of the 23 residue peptide h-REKR, designed to exhibit a large N terminal helix, followed by the gp160 native sequence, Arg508-Gly516, h-REKR is digested by furin with high efficiency comparable to the full native p498. Circular dichroism analyses, in mixtures from pure water to 98% trifluoroethanol, outline a significant content of helical structure in the peptide conformation. The molecular model obtained from NMR data collected in trifluoroethanol/water, by means of DYANA and AMBER simulations, indeed has helical structure on a large N-terminal segment. Such a long helix does not seem to affect the loop conformation of the C-terminal site 1-containing sequence, which exhibits the same proton chemical shifts already observed for the full native p498.
引用
收藏
页码:727 / 733
页数:7
相关论文
共 50 条
  • [41] Heparan sulfate targets the HIV-1 envelope glycoprotein gp120 coreceptor binding site
    Vivès, RR
    Imberty, A
    Sattentau, QJ
    Lortat-Jacob, H
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (22) : 21353 - 21357
  • [42] Lymphoproliferative response to synthetic V3 loop P18 peptide and HIV-1 envelope glycoprotein among individuals immunized with gp160 candidate vaccines
    Moukrim, Z
    Cho, YY
    Mbika, JP
    Achour, A
    BIOMEDICINE & PHARMACOTHERAPY, 1996, 50 (10) : 494 - 499
  • [43] Inhibition of the calcium release-activated calcium (CRAC) current in Jurkat T cells by the HIV-1 envelope protein gp160
    Dellis, O
    Gangloff, SC
    Paulais, M
    Tondelier, D
    Rona, JP
    Brouillard, F
    Bouteau, F
    Guenounou, M
    Teulou, J
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (08) : 6044 - 6050
  • [44] HUMAN IMMUNODEFICIENCY VIRUS-1 (HIV-1) ENVELOPE PROTEIN, GP160, INDUCES TYROSINE PHOSPHORYLATION IN HUMAN T-CELLS
    YAGURA, H
    OYAIZU, N
    CHIRMULE, N
    KALYANARAMAN, VS
    HU, R
    PAHWA, S
    JOURNAL OF IMMUNOLOGY, 1993, 150 (08): : A112 - A112
  • [45] Gene gun DNA vaccination with Rev-independent synthetic HIV-1 gp160 envelope gene using mammalian codons
    Vinner, L
    Nielsen, HV
    Bryder, K
    Corbet, S
    Nielsen, C
    Fomsgaard, A
    VACCINE, 1999, 17 (17) : 2166 - 2175
  • [46] INHIBITORY EFFECT OF HIV-1 ENVELOPE GLYCOPROTEINS GP120 AND GP160 ON THE INVITRO GROWTH OF ENRICHED (CD34+) HEMATOPOIETIC PROGENITOR CELLS
    ZAULI, G
    RE, MC
    VISANI, G
    FURLINI, G
    LAPLACA, M
    ARCHIVES OF VIROLOGY, 1992, 122 (3-4) : 271 - 280
  • [47] The interactions of the N-terminal fusogenic peptide of HIV-1 gp41 with neutral phospholipids
    Curtain, C
    Separovic, F
    Nielsen, K
    Craik, D
    Zhong, Y
    Kirkpatrick, A
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 1999, 28 (05): : 427 - 436
  • [48] The interactions of the N-terminal fusogenic peptide of HIV-1 gp41 with neutral phospholipids
    C. Curtain
    Frances Separovic
    Katherine Nielsen
    David Craik
    Yong Zhong
    Alan Kirkpatrick
    European Biophysics Journal, 1999, 28 : 427 - 436
  • [49] IMPROVED CELL-MEDIATED IMMUNE-RESPONSES IN HIV-1-INFECTED ASYMPTOMATIC INDIVIDUALS AFTER IMMUNIZATION WITH ENVELOPE GLYCOPROTEIN GP160
    WAHREN, B
    BRATT, G
    PERSSON, C
    LEVEN, B
    HINKULA, J
    GILLJAM, G
    NORDLUND, S
    ERIKSSON, L
    VOLVOVITZ, S
    BROLIDEN, PA
    SANDSTROM, E
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1994, 7 (03): : 220 - 229
  • [50] N36, a synthetic N-terminal heptad repeat domain of the HIV-1 envelope protein gp41, is an activator of human phagocytes
    Le, YY
    Jiang, S
    Hu, JY
    Gong, WH
    Su, SB
    Dunlop, NM
    Shen, WP
    Li, BQ
    Wang, JM
    CLINICAL IMMUNOLOGY, 2000, 96 (03) : 236 - 242